A cost-benefit analysis of the ENIGMA trial

Anesthesiology

Volumn 115, Issue 2, 2011, Pages 265-272

  Graham, Alison M ^a   Myles, Paul S ^a,b,c   Leslie, Kate ^d,e   Chan, Matthew T V ^f   Paech, Michael J ^g,h   Peyton, Philip ⁱ   El Dawlatly, Abdelazeem A ^j  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h KING EDWARD MEMORIAL HOSPITAL   (Australia)

ⁱ AUSTIN HOSPITAL   (Australia)

^j KING SAUD UNIVERSITY   (Saudi Arabia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INHALATION ANESTHETIC AGENT; NITROUS OXIDE; PROPOFOL;

ABDOMINAL SURGERY; ADULT; ARTICLE; COLORECTAL SURGERY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; EAR NOSE THROAT SURGERY; ECONOMIC EVALUATION; FEMALE; GENERAL ANESTHESIA; GENERAL SURGERY; GYNECOLOGIC SURGERY; HEALTH CARE COST; HOSPITALIZATION COST; HUMAN; INHALATION ANESTHESIA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MULTICENTER STUDY; NEUROSURGERY; ORTHOPEDIC SURGERY; PLASTIC SURGERY; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SURGICAL INFECTION; UROLOGIC SURGERY; VASCULAR SURGERY;

EID: 79961061053     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31821f659c     Document Type: Article

References (73)

1. Myles PS, Leslie K, Chan MT, Forbes A, Paech MJ, Peyton P, Silbert BS, Pascoe E, ENIGMA Trial Group: Avoidance of nitrous oxide for patients undergoing major surgery: A randomized controlled trial. ANESTHESIOLOGY 2007;107:221-31 (Pubitemid 47196484)
2. Sharma D: Nitrous oxide: Time to laugh it off? Not quite. Anesthesiology 2008;108:541-2
3. Drummond MF, Jefferson D: Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party BMJ 1996;313:275-83 (Pubitemid 26254740)
4. Weinberg L, Story D, Nam J, McNicol L: Pharmacoeconomics of volatile inhalational anaesthetic agents: An 11-year retrospective analysis. Anaesth Intensive Care 2010;38:849-54
5. Dalgleish D, Fletcher M: Oxygen wastage. Anaesthesia 2007;62:1188
6. Dion P: The cost of anaesthetic vapours. Can J Anaesth 1992;39:633-4
7. Ballantyne JC, Chang Y: The impact of choice of muscle relaxant on postoperative recovery time: A retrospective study. Anesth Analg 1997;85:476-82 (Pubitemid 27381293)
8. Chan VW, Peng PW, Kaszas Z, Middleton WJ, Muni R, Anastakis DG, Graham BA: A comparative study of general anesthesia, intravenous regional anesthesia, and axillary block for outpatient hand surgery: Clinical outcome and cost analysis. Anesth Analg 2001;93:1181-4 (Pubitemid 33021012)
9. Kain ZN, Gaal DJ, Kain TS, Jaeger DD, Rimar S: A first-pass cost analysis of propofol versus barbiturates for children undergoing magnetic resonance imaging. Anesth Analg 1994;79:1102-06 (Pubitemid 24363613)
10. Carroll NV, Miederhoff PA, Cox FM, Hirsch JD: Costs incurred by outpatient surgical centers in managing postoperative nausea and vomiting. J Clin Anesth 1994;6:364-9 (Pubitemid 24302201)
11. Hill RP, Lubarsky DA, Phillips-Bute B, Fortney JT, Creed MR, Glass PS, Gan TJ: Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol or placebo. ANESTHESIOLOGY 2000;92:958-67 (Pubitemid 30180971)
12. Pueyo FJ, Olaondo L, Sanchez-Ledesma MJ, Ortega A, Carrascosa F: Cost-effectiveness of three combinations of antiemetics in the prevention of postoperative nausea and vomiting. Br J Anaesth 2003;91:589-92 (Pubitemid 37258606)
13. Watcha MF, Smith I: Cost-effectiveness analysis of antiemetic therapy for ambulatory surgery. J Clin Anesth 1994;6:370-7 [letter] (Pubitemid 24302202)
14. Zarate E, Watcha MF, White PF, Klein KW, Sa Rego M, Stewart DG: A comparison of the costs and efficacy of ondansetron versus dolasetron for antiemetic prophylaxis. Anesth Analg 2000;90:1352-8 (Pubitemid 30351336)
15. Alfonso JL, Pereperez SB, Canoves JM, Martinez MM, Martinez IM, Martin-Moreno JM: Are we really seeing the total costs of surgical site infections? A Spanish study. Wound Repair Regen 2007;15:474-81 (Pubitemid 47087639)
16. Brown PP, Kugelmass AD, Cohen DJ, Reynolds MR, Culler SD, Dee AD, Simon AW: The frequency and cost of complications associated with coronary artery bypass grafting surgery: Results from the United States Medicare program. Ann Thorac Surg 2008;85:1980-6 (Pubitemid 351695490)
17. Coello R, Charlett A, Wilson J, Ward V, Pearson A, Borriello P: Adverse impact of surgical site infections in English hospitals. J Hosp Infect 2005;60:93-103 (Pubitemid 40590575)
18. Coello R, Glenister H, Fereres J, Bartlett C, Leigh D, Sedgwick J, Cooke EM: The cost of infection in surgical patients: A case-control study. J Hosp Infect 1993;25:239-50 (Pubitemid 24042248)
19. Coskun D, Aytac J, Aydinli A, Bayer A: Mortality rate, length of stay and extra cost of sternal surgical site infections following coronary artery bypass grafting in a private medical centre in Turkey. J Hosp Infect 2005;60:176-9 (Pubitemid 40590588)
20. Dimick JB, Chen SL, Taheri PA, Henderson WG, Khuri SF, Campbell DA Jr: Hospital costs associated with surgical complications: A report from the private-sector National Surgical Quality Improvement Program. J Am Coll Surg 2004;199:531-7 (Pubitemid 39420202)
21. Haley RW, Schaberg DR, Crossley KB, Von Allmen SD, McGowan JE Jr: Extra charges and prolongation of stay attributable to nosocomial infections: A prospective interhospital comparison. Am J Med 1981;70:51-8 (Pubitemid 11183516)
22. Hall RE, Ash AS, Ghali WA, Moskowitz MA: Hospital cost of complications associated with coronary artery bypass graft surgery. Am J Cardiol 1997;79:1680-2 (Pubitemid 27339483)
23. Herwaldt LA, Cullen JJ, Scholz D, French P, Zimmerman MB, Pfaller MA, Wenzel RP, Perl TM: A prospective study of outcomes, healthcare resource utilization, and costs associated with postoperative nosocomial infections. Infect Control Hosp Epidemiol 2006;27:1291-8 (Pubitemid 46052274)
24. Hollenbeak CS, Murphy D, Dunagan WC, Fraser VJ: Nonrandom selection and the attributable cost of surgical-site infections. Infect Control Hosp Epidemiol 2002;23:177-82 (Pubitemid 34297270)
25. Jenney AW, Harrington GA, Russo PL, Spelman DW: Cost of surgical site infections following coronary artery bypass surgery. ANZ J Surg 2001;71:662-4 (Pubitemid 33071028)
26. Kasatpibal N, Thongpiyapoom S, Narong MN, Suwalak N, Jamulitrat S: Extra charge and extra length of postoperative stay attributable to surgical site infection in six selected operations. J Med Assoc Thai 2005;88:1083-91 (Pubitemid 41411532)
27. Khan NA, Quan H, Bugar JM, Lemaire JB, Brant R, Ghali WA: Association of postoperative complications with hospital costs and length of stay in a tertiary care center. J Gen Intern Med 2006;21:177-80 (Pubitemid 43363675)
28. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ: The impact of surgical-site infections in the 1990s: Attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999;20:725-30
29. de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB: Surgical site infection: Incidence and impact on hospital utilization and treatment costs. Am J Infect Control 2009;37:387-97
30. Mahmoud NN, Turpin RS, Yang G, Saunders WB: Impact of surgical site infections on length of stay and costs in selected colorectal procedures. Surg Infect 2009;10:539-44
31. McGarry SA, Engemann JJ, Schmader K, Sexton DJ, Kaye KS: Surgical-site infection due to Staphylococcus aureus among elderly patients: Mortality, duration of hospitalization, and cost. Infect Control Hosp Epidemiol 2004;25:461-7 (Pubitemid 38758489)
32. Mugford M, Kingston J, Chalmers I: Reducing the incidence of infection after caesarean section: Implications of prophylaxis with antibiotics for hospital resources. BMJ 1989;299:1003-6 (Pubitemid 19256327)
33. Olsen MA, Chu-Ongsakul S, Brandt KE, Dietz JR, Mayfield J, Fraser VJ: Hospital-associated costs due to surgical site infection after breast surgery. Arch Surg 2008;143:53-60; discussion 61 (Pubitemid 351159291)
34. Penel N, Lefebvre JL, Cazin JL, Clisant S, Neu JC, Dervaux B, Yazdanpanah Y: Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: A hospital-perspective analysis. Int J Oral Maxillofac Surg 2008;37:135-9 (Pubitemid 351220977)
35. Plowman R, Graves N, Griffin MA, Roberts JA, Swan AV, Cookson B, Taylor L: The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 2001;47:198-209 (Pubitemid 32631848)
36. Pollard TC, Newman JE, Barlow NJ, Price JD, Willett KM: Deep wound infection after proximal femoral fracture: Consequences and costs. J Hosp Infect 2006;63:133-9
37. Rubinstein E, Green M, Modan M, Amit P, Bernstein L, Rubinstein A: The effects of nosocomial infections on the length and costs of hospital stay. J Antimicrob Chemother 1982;9:93-100 (Pubitemid 12151219)
38. Schäfer U: Cost analysis in nosocomial infections. A 1-year study in the Surgical Department of Riesa District Hospital. Zentralbl Chir 1987;112:1552-60 (Pubitemid 18037104)
39. Sheng WH, Chie WC, Chen YC, Hung CC, Wang JT, Chang SC: Impact of nosocomial infections on medical costs, hospital stay, and outcome in hospitalized patients. J Formos Med Assoc 2005;104:318-26
40. Upton A, Smith P, Roberts S: Excess cost associated with Staphylococcus aureus poststernotomy mediastinitis. N Z Med J 2005;118:1-4
41. Urban J: Cost analysis of surgical site infections. Surg Infect 2006;7:S19-22
42. Vegas AA, Jodra VM, García ML: Nosocomial infection in surgery wards: A controlled study of increased duration of hospital stays and direct cost of hospitalization. Eur J Epidemiol 1993;9:504-10 (Pubitemid 23361957)
43. Weber WP, Zwahlen M, Reck S, Feder-Mengus C, Misteli H, Rosenthal R, Brandenberger D, Oertli D, Widmer AF, Marti WR: Economic burden of surgical site infections at a European university hospital. Infect Control Hosp Epidemiol 2008;29:623-9 (Pubitemid 352009387)
44. Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ: The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: Adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002;23:183-9 (Pubitemid 34297271)
45. Zoutman D, McDonald S, Vethanayagan D: Total and attributable costs of surgical-wound infections at a Canadian tertiary-care center. Infect Control Hosp Epidemiol 1998;19:254-9 (Pubitemid 128472672)
46. Dietrich ES, Demmler M, Schulgen G, Fekec K, Mast O, Pelz K, Daschner FD: Nosocomial pneumonia: A cost-of-illness analysis. Infection 2002;30:61-7 (Pubitemid 34293368)
47. Muscedere JG, Martin CM, Heyland DK: The impact of ventilator-associated pneumonia on the Canadian health care system. J Crit Care 2008;23:5-10 (Pubitemid 351400351)
48. Thompson DA, Makary MA, Dorman T, Pronovost PJ: Clinical and economic outcomes of hospital acquired pneumonia in intra-abdominal surgery patients. Ann Surg 2006;243:547-52
49. Edbrooke DL, Stevens VG, Hibbert CL, Mann AJ, Wilson AJ: A new method of accurately identifying costs of individual patients in intensive care: The initial results. Intensive Care Med 1997;23:645-50 (Pubitemid 27312043)
50. McLaughlin AM, Hardt J, Canavan JB, Donnelly MB: Determining the economic cost of ICU treatment: A prospective "micro-costing" study. Intensive Care Med 2009;35:2135-40
51. Moerer O, Plock E, Mgbor U, Schmid A, Schneider H, Bernd Wischnewsky M, Burchardi H: A German national prevalence study on the cost of intensive care: An evaluation from 51 intensive care units. Crit Care 2007;11:R69
52. Moran JL, Peisach AR, Solomon PJ, Martin J: Cost calculation and prediction in adult intensive care: A ground-up utilization study. Anaesth Intensive Care 2004;32:787-97 (Pubitemid 40081334)
53. Norris C, Jacobs P, Rapoport J, Hamilton S: ICU and non-ICU cost per day. Can J Anaesth 1995;42:192-6
54. Noseworthy TW, Konopad E, Shustack A, Johnston R, Grace M: Cost accounting of adult intensive care: Methods and human and capital inputs. Crit Care Med 1996;24:1168-72 (Pubitemid 26249368)
55. Parno JR, Teres D, Lemeshow S, Brown RB Hospital charges and long-term survival of ICU versus non-ICU patients. Crit Care Med 1982;10:569-75
56. Rechner IJ, Lipman J: The costs of caring for patients in a tertiary referral Australian intensive care unit. Anaesth Intensive Care 2005;33:177-82
57. Ridley S, Biggam M, Stone P: Cost of intensive therapy: A description of methodology and initial results. Anaesthesia 1991;46:523-30
58. Slatyer MA, James OF, Moore PG, Leeder SR: Costs, severity of illness and outcome in intensive care. Anaesth Intensive Care 1986;14:381-9 (Pubitemid 17179727)
59. Girotti MJ, Brown SJ: Reducing the costs of ICU admission in Canada without diagnosis-related or case-mix groupings. Can Anaesth Soc J 1986;33:765-72 (Pubitemid 17181002)
60. Stephen AE, Berger DL: Shortened length of stay and hospital cost reduction with implementation of an accelerated clinical care pathway after elective colon resection. Surgery 2003;133:277-82 (Pubitemid 36390789)
61. Lemmens L, van Zelm R, Vanhaecht K, Kerkkamp H: Systematic review: Indicators to evaluate effectiveness of clinical pathways for gastrointestinal surgery. J Eval Clin Pract 2008;14:880-7
62. Briggs A, Gray A: The distribution of health care costs and their statistical analysis for economic evaluation. J Health Serv Res Policy 1998;3:233-45 (Pubitemid 28479263)
63. Barber JA, Thompson SG: Analysis of cost data in randomized trials: An application of the non-parametric bootstrap. Stat Med 2000;19:3219-36
64. Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N: A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess 2007;11:1-160
65. Poulsen KB, Bremmelgaard A, Srensen AI, Raahave D, Petersen JV: Estimated costs of postoperative wound infections A case-control study of marginal hospital and social security costs. Epidemiol Infect 1994;113:283-95 (Pubitemid 24310317)
66. Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R: Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis 2003;9:196-203 (Pubitemid 36231790)
67. McPeek B: Inference, generalizability, and a major change in anesthetic practice. ANESTHESIOLOGY 1987;66:723-4
68. Gan TJ, Sloan F, Dear Gde L, El-Moalem HE, Lubarsky DA: How much are patients willing to pay to avoid postoperative nausea and vomiting? Anesth Analg 2001;92:393-400 (Pubitemid 32127625)
69. Kerger H, Turan A, Kredel M, Stuckert U, Alsip N, Gan TJ, Apfel CC: Patients' willingness to pay for anti-emetic treatment. Acta Anaesthesiol Scand 2007;51:38-43 (Pubitemid 44968022)
70. Macario A, Weinger M, Carney S, Kim A: Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg 1999;89:652-8 (Pubitemid 29409815)
71. van den Bosch JE, Bonsel GJ, Moons KG, Kalkman CJ: Effect of postoperative experiences on willingness to pay to avoid postoperative pain, nausea, and vomiting. ANESTHESIOLOGY 2006;104:1033-9
72. Dexter F, Tinker JH: Analysis of strategies to decrease postanesthesia care unit costs. ANESTHESIOLOGY 1995;82:94-101
73. Cohen MM, O'Brien-Pallas LL, Copplestone C, Wall R, Porter J, Rose DK: Nursing workload associated with adverse events in the postanesthesia care unit. ANESTHESIOLOGY 1999;91:1882-90